Doremon, Nelson .

HRN: 27-25-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
CEFTRIAXONE 1G (VIAL)
06/07/2025
06/14/2025
IV
2 Grams
OD
CAP MR
Checking Initial Appropriateness 
06/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2025
06/14/2025
IV
500
Q8
Choledocholithiasis
Checking Initial Appropriateness 
06/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2025
06/13/2025
IVT
500mg
Q6
Cholecystitis, T/c Cholangitis In Progression 2. HAP
Checking Initial Appropriateness 
06/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/07/2025
06/13/2025
IVT
4.5g
Q8
Cholecystitis, T/c Cholangitis In Progression 2. HAP
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: